Get the Stockscreener App
0.95
5.00%
-0.05
After Hours:
.95
Therapeuticsmd Inc Stock (TXMD) Latest News
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
How does TXMD’s price to cash per share ratio compare in the market? - US Post News
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD) - Defense World
TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch
TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
TherapeuticsMD (NASDAQ:TXMD) Coverage Initiated at StockNews.com - Defense World
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
3 Promising US Penny Stocks With Over $9M Market Cap - Simply Wall St
StockNews.com Initiates Coverage on TherapeuticsMD (NASDAQ:TXMD) - Defense World
TXMD stock touches 52-week low at $1.04 amid market challenges - Investing.com Nigeria
TXMD stock touches 52-week low at $1.04 amid market challenges By Investing.com - Investing.com South Africa
TherapeuticsMD Inc. stock remains steady Friday, still outperforms market - MarketWatch
TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com - Defense World
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
TXMD stock touches 52-week low at $1.13 amid market challenges By Investing.com - Investing.com South Africa
TXMD stock touches 52-week low at $1.13 amid market challenges - Investing.com India
TherapeuticsMD Inc. stock remains steady Thursday, still outperforms market - MarketWatch
3.69%
1.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):